3V7D
 
 | | Crystal Structure of ScSkp1-ScCdc4-pSic1 peptide complex | | Descriptor: | Cell division control protein 4, Protein SIC1, Suppressor of kinetochore protein 1 | | Authors: | Tang, X, Orlicky, S, Mittag, T, Csizmok, V, Pawson, T, Forman-Kay, J, Sicheri, F, Tyers, M. | | Deposit date: | 2011-12-20 | | Release date: | 2012-05-02 | | Last modified: | 2023-09-13 | | Method: | X-RAY DIFFRACTION (2.306 Å) | | Cite: | Composite low affinity interactions dictate recognition of the cyclin-dependent kinase inhibitor Sic1 by the SCFCdc4 ubiquitin ligase.
Proc.Natl.Acad.Sci.USA, 109, 2012
|
|
8DWT
 | | SPOP W22R Form 2 | | Descriptor: | Speckle-type POZ protein | | Authors: | Cuneo, M.J, Mittag, T, O'Flynn, B, Lo, Y.H. | | Deposit date: | 2022-08-02 | | Release date: | 2023-01-18 | | Last modified: | 2024-06-12 | | Method: | ELECTRON MICROSCOPY (6.2 Å) | | Cite: | Higher-order SPOP assembly reveals a basis for cancer mutant dysregulation.
Mol.Cell, 83, 2023
|
|
8DWV
 | | Full-length wild type SPOP | | Descriptor: | Speckle-type POZ protein | | Authors: | Cuneo, M.J, Mittag, T, O'Flynn, B, Lo, Y.H. | | Deposit date: | 2022-08-02 | | Release date: | 2023-01-18 | | Last modified: | 2023-03-22 | | Method: | ELECTRON MICROSCOPY (3.6 Å) | | Cite: | Higher-order SPOP assembly reveals a basis for cancer mutant dysregulation.
Mol.Cell, 83, 2023
|
|
8DWU
 | | SPOP W22R Form 1 | | Descriptor: | Speckle-type POZ protein | | Authors: | Cuneo, M.J, Mittag, T, O'Flynn, B. | | Deposit date: | 2022-08-02 | | Release date: | 2023-01-18 | | Last modified: | 2024-06-12 | | Method: | ELECTRON MICROSCOPY (3.4 Å) | | Cite: | Higher-order SPOP assembly reveals a basis for cancer mutant dysregulation.
Mol.Cell, 83, 2023
|
|
8DWS
 | | Full-length E47K SPOP | | Descriptor: | Speckle-type POZ protein | | Authors: | Cuneo, M.J, Mittag, T, O'Flynn, B, Lo, Y.H. | | Deposit date: | 2022-08-02 | | Release date: | 2023-01-18 | | Last modified: | 2023-03-22 | | Method: | ELECTRON MICROSCOPY (3.73 Å) | | Cite: | Higher-order SPOP assembly reveals a basis for cancer mutant dysregulation.
Mol.Cell, 83, 2023
|
|
